Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 152.00 / 3.38M |
Day Range | - - - |
52 Wk Range | 8.79 - 42.20 |
Market Cap | $1.44B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 35.18% |
Days to Cover | 10.38 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.
Other companies in Cassava Sciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Neumora Therapeutics (NASDAQ:NMRA).
Cassava Sciences has a consensus price target of $75.50.
The stock price for Cassava Sciences (NASDAQ: SAVA) is $29.9599 last updated September 20, 2024 at 6:58 PM EDT.
A quarterly cash dividend of 0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.
Cassava Sciences’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Cassava Sciences.
Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.